Stock Scorecard



Stock Summary for Amarin Corp (AMRN) - $14.74 as of 2/16/2026 7:08:40 PM EST

Total Score

11 out of 30

Safety Score

31 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for AMRN

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for AMRN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for AMRN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for AMRN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for AMRN (31 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 8
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 2
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for AMRN

Do Options Traders Know Something About Amarin Stock We Don't? 1/20/2026 1:58:00 PM
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights 1/10/2026 8:13:00 PM
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations 1/10/2026 3:29:00 PM
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights 1/10/2026 2:57:00 PM
Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization 1/9/2026 3:57:00 PM
Amarin highlights VASCEPA’s role amid new triglyceride therapies 1/9/2026 12:26:00 PM
Why a low-cost heart pill could be tried before pricey new shots 1/9/2026 12:26:00 PM
Amarin Corporation Discusses Impact of Emerging Triglyceride Therapies on Treatment Strategies and Patient Access 1/9/2026 12:03:00 PM
AMRN Stock Up 17% as Preliminary Q4 Sales Beat Expectations 1/9/2026 11:46:00 AM
Heart drug maker Amarin turns cash positive after 25M prescriptions 1/8/2026 10:09:00 PM

Financial Details for AMRN

Company Overview

Ticker AMRN
Company Name Amarin Corp
Country USA
Description Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 9/30/2025
Next Earnings Date 2/25/2026

Stock Price History

Last Day Price 14.74
Price 4 Years Ago 24.20
Last Day Price Updated 2/16/2026 7:08:40 PM EST
Last Day Volume 43,832
Average Daily Volume 88,065
52-Week High 20.90
52-Week Low 7.00
Last Price to 52 Week Low 110.57%

Valuation Measures

Trailing PE N/A
Industry PE 35.22
Sector PE 68.60
5-Year Average PE -48.17
Free Cash Flow Ratio 2.49
Industry Free Cash Flow Ratio 39.88
Sector Free Cash Flow Ratio 27.98
Current Ratio Most Recent Quarter 3.45
Total Cash Per Share 5.91
Book Value Per Share Most Recent Quarter 22.06
Price to Book Ratio 0.67
Industry Price to Book Ratio 14.18
Sector Price to Book Ratio 37.88
Price to Sales Ratio Twelve Trailing Months 1.35
Industry Price to Sales Ratio Twelve Trailing Months 5.79
Sector Price to Sales Ratio Twelve Trailing Months 24.89
Analyst Buy Ratings 0
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 20,792,700
Market Capitalization 306,484,398
Institutional Ownership 20.75%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.12%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -94.20%
Annual Earnings Growth -39.03%
Reported EPS 12 Trailing Months -4.20
Reported EPS Past Year -0.83
Reported EPS Prior Year -0.09
Net Income Twelve Trailing Months -86,192,000
Net Income Past Year -82,183,000
Net Income Prior Year -59,112,000
Quarterly Revenue Growth YOY 17.40%
5-Year Revenue Growth -11.86%
Operating Margin Twelve Trailing Months -3.42%

Balance Sheet

Total Cash Most Recent Quarter 122,802,000
Total Cash Past Year 121,038,000
Total Cash Prior Year 199,252,000
Net Cash Position Most Recent Quarter 122,802,000
Net Cash Position Past Year 121,038,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 486,176,000
Total Stockholder Equity Prior Year 552,097,000
Total Stockholder Equity Most Recent Quarter 458,894,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -21,859,898
Free Cash Flow Per Share Twelve Trailing Months -1.05
Free Cash Flow Past Year -31,020,000
Free Cash Flow Prior Year 6,882,570

Options

Put/Call Ratio 0.09
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.07
MACD Signal -0.02
20-Day Bollinger Lower Band 12.50
20-Day Bollinger Middle Band 16.05
20-Day Bollinger Upper Band 19.59
Beta 0.86
RSI 47.76
50-Day SMA 14.06
150-Day SMA 16.30
200-Day SMA 19.97

System

Modified 2/16/2026 5:12:28 PM EST